Vaccination af raske børn i alderen 12-22 måneder mod mæslinger, fåresyge, røde hunde og skoldkopper

Research

Print page

Switch language

The Capital Region of Denmark - a part of Copenhagen University Hospital

Project

From the same participant

Acute Respiratory Symptoms and General Illness During the First Year of Life: A Population-based Birth Cohort Study
Project
Antibiotics for Pertussis: A Systematic Review
Project
Excretion Patterns of Human Metapneumovirus and Respiratory Syncytial Virus among Young Children
Project
Recombinant polyclonal anti-respiratory syncytial virus preparation for prevention of severe respiratory disease
Project
Rotavirus Infection in Young Children
Project
Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine.
Project
Saliva as a Potential Vehichle of Transmission of Hepatitis B Virus from Children with Chronic Hepatitis B Infection
Project
Skyldes epidemien af Methicillin resistente Staphylococcus aureus (MRSA) i Danmark en øget forekomst af methicillin resistente coagulase negative stafylokokker
Project
The role of Hepatitis B Virus Genotypes in the outcomes of Hepatitis B Virus Infection.
Project
Sequelae following invasive Streptococcus pneumoniae infection in children
Project

Høgh, Birthe (Project Manager, organisational)
Heiberg, Ida Louise (Project participant)
Pontoppidan, Peter Erik Lotko (Project participant)
hoffmann, Thomas (Project participant)

Department of Pediatrics, Copenhagen University Hospital, Hvidovre, Denmark

View graph of relations

An open-label multicentre study on safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine Proquad manufactured with recombinant human albumin (rHA) when administered to children in their second year of life.

Status	Completed
Period	18-07-11 → …
URL	http://clinicaltrials.gov/ct2/show/record/NCT00560755?rcv_s=11%2F17%2F2007

Research programme	<ingen navn>

ID: 32577588